Boston Sci launches hemostasis clip to control bleeding in GI endoscopy

Resolution 360 clip--Courtesy of Boston Scientific

Boston Scientific launched a new tool for hemostatic clipping, a technique used in some endoscopic procedures of the gastrointestinal system to stop and prevent bleeding.

There are more than 240,000 occurrences of gastrointestinal bleeding in the U.S. each year, the company said in a statement. These can stem from peptic ulcers, the removal of polyps during colonoscopy and diverticulosis of the colon. Globally, the mortality rate associated with upper and lower GI bleeding is 10%.

Boston Sci’s Resolution 360 Clip is built using a multiwire braided catheter, which allows the physician to rotate the device in small, controlled movements, the company said in the statement. This facilitates the accurate placement of the clip at a bleed site or potential bleed site in the gastrointestinal tract.


Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

"The Resolution 360 Clip gives me the unique advantage of controlling the movement and placement of the clip while also maneuvering the scope during the clipping procedure," said Dr. David Carr-Locke, chief of Mount Sinai’s division of digestive diseases, in the statement. "The ability to have complete control can help improves the accuracy of clip placement and the speed of the procedure particularly in complex cases."

The company is presenting the clip at the United European Gastroenterology Week and at the American College of Gastroenterology’s annual meeting this week.

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.